Originally from the East Coast, I sought out sunny California and became an industry scientist. A few years later I changed careers and moved to Stanford to follow my passion for diversity in STEM.
I am an Assistant Dean in the Office of Multicultural Affairs, School of Earth, Energy, and Environmental Sciences (http://oma.stanford.edu). I am interested in knowledge building, process improvement, and behavioral change to identify, recruit and retain the best academic talent. I specialize in graduate student diversity and inclusion.
Honors & Awards
President's Award for Excellence Through Diversity, Office of Multicultural Affairs (2015-2016)
Education & Certifications
PhD, University of Rochester, Toxicology
BS, Mary Baldwin College, Chemistry
-Diversity and Inclusion in STEM, Academia, Graduate Admissions and Faculty Hiring
-Toxicology and Environmental Health
A soluble BAFF antagonist, BR3-Fc, decreases peripheral blood B cells and lymphoid tissue marginal zone and follicular B cells in cynomolgus monkeys
AMERICAN JOURNAL OF PATHOLOGY
2006; 168 (2): 476-489
BAFF (also known as BLyS), a member of the tumor necrosis factor superfamily, plays a critical role in the maturation and development of B cells. BAFF has three receptors on B cells, the most crucial of which is BR3. In this study, we demonstrate the biological outcome of BAFF blockade in cynomolgus monkeys using a soluble fusion protein consisting of human BR3 and human IgG1 Fc. In vitro, BR3-Fc blocked BAFF-mediated survival and proliferation of cynomolgus monkey B cells. Weekly treatment of cynomolgus monkeys with BR3-Fc for 13 to 18 weeks resulted in significant B-cell reduction in the peripheral blood and in lymphoid organs. CD21(high) B cells in lymphoid tissues, a subset analogous to human marginal zone B cells, expressed nearly twofold higher BR3 levels than did CD21(med) B cells. Lymphoid tissue flow cytometric analysis showed that BR3-Fc reduced this CD21(high) B-cell subset to a greater extent than it reduced CD21(med) B cells. Dual-label immunohistochemistry and morphometric image analysis supported these results by demonstrating that BR3-Fc reduced a significant proportion of the B cells within the splenic inner and outer marginal zones. These findings should prove very useful in guiding the desired therapeutic use of BR3-Fc for autoimmune diseases in the clinic.
View details for DOI 10.2353/ajpath.2006.050600
View details for Web of Science ID 000235122600012
View details for PubMedID 16436662
Altered lung gene expression in CCSP-null mice suggests immunoregulatory roles for Clara cells
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY
2001; 281 (6): L1523-L1530
Clara cell secretory protein (CCSP) is one of the most abundant proteins present in airway lining fluid of mammals. In an effort to elucidate the function of CCSP, we established CCSP-null [CCSP(-/-)] mice and demonstrated altered sensitivity to various environmental agents including oxidant pollutants and microorganisms. Although CCSP deficiency itself may be central to the observed changes in environmental susceptibility, altered lung gene expression associated with CCSP deficiency may contribute to the observed phenotype. To determine whether CCSP deficiency results in altered lung gene expression, high-density cDNA microarrays were used to profile gene expression in the total lung RNA of wild-type and CCSP(-/-) mice. Genes that were differentially expressed between wild-type and CCSP(-/-) mice included a previously non-annotated expressed sequence tag (EST W82219) and immunoglobulin A (IgA), both of which were elevated with CCSP deficiency. mRNA expression of EST W82219 and IgA was localized in the lungs of wild-type and CCSP(-/-) mice to airway Clara cells and peribronchial lymphoid tissues, respectively. We conclude that CCSP deficiency is associated with 1) altered gene expression in Clara cells of the conducting airway epithelium and 2) alterations to peribronchial B lymphocytes. These findings identify new roles for Clara cells and their secretions in airway homeostasis.
View details for Web of Science ID 000172094400026
View details for PubMedID 11704549